Cryonics Explained: Could It Help Us Live Longer?

In this segment Dr. Jeffrey Gladden explains how age‑related involution of the thymus gland impairs the production of new T‑cells, leading to an aging immune system that eventually fails to respond to infections, clear senescent cells, or eliminate emerging cancers. He describes a reported biochemical protocol—growth hormone, DHEA (a precursor hormone), and metformin—that aims to rejuvenate the thymus. The combination activates AMPK (promoting longevity) while counteracting mTOR activation from growth hormone, creating a balanced approach. According to the cited study, participants experienced a reversal of epigenetic age by roughly one to one and a half years within a year of treatment. Gladden emphasizes that immunosenescence is a major cause of mortality, making thymic rejuvenation a potential strategy for extending healthy lifespan.










